Late-Breaking Trials in transcatheter mitral, tricuspid and aortic interventions - Part 1

AltaValve early feasibility study, TARGET study (Cardiovalve), transapical TMVR five-year outcomes, and ALIGN-AR registry

Anchorperson: J. Granada

Spokesperson: F. Geraldes

Summary

This session presents pivotal late-breaking trials in transcatheter mitral and aortic valve interventions. Explore one-year outcomes from the AltaValve early feasibility study featuring atrial fixation TMVR, interim results from the TARGET study assessing Cardiovalve for tricuspid regurgitation, five-year data on transapical TMVR, and outcomes of TAVI for aortic regurgitation in high surgical risk patients from the ALIGN-AR registry.

Presentations available when logged in:

AltaValve early feasibility study: one-year outcomes with atrial fixation TMVR
Safety and performance of Cardiovalve replacement system for tricuspid regurgitation: TARGET study interim results
Five-year outcomes following early experience with transapical TMVR
TAVI for aortic regurgitation in high surgical risk: outcomes in 700 patients from ALIGN-AR

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Late-Breaking Trials in transcatheter mitral, tricuspid and aortic interventions - Part 1

AltaValve early feasibility study, TARGET study (Cardiovalve), transapical TMVR five-year outcomes, and ALIGN-AR registry

Log in or create account for free